Shandong Cancer Hospital and Institute clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 105 studies whose lead sponsor is Shandong Cancer Hospital and Institute. 38 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 15, 2026.
Keep track of what changes. Save the Shandong Cancer Hospital and Institute studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesWhere
- China
- 86
Focus areas
Conditions Shandong Cancer Hospital and Institute leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 105. Browse all 105 →
- Sintilimab Combined With Chemotherapy and Radiotherapy in Patients With Inoperable Pancreatic CancerRecruitingNCT06050317Phase 2
- Neoadjuvant Radiotherapy for Rectal Adenocarcinoma With Capecitabine Versus TAS-102 (Neo-REACT): A Multi-center, Randomized, Phase III TrialRecruitingNCT06850090Phase 3
- Concordance Between Large Language Model and Multidisciplinary Team Recommendations in Rectal CancerRecruitingNCT07595107
- BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + Surgery/SBRT for BCLC-C HCC With PVTT and/or OligometastasesRecruitingNCT07062055Phase 2
- Delayed Systemic Therapy Following Destructive Local Treatment of Pulmonary Oligometastases After No Evidence of Disease (NED) in Colorectal Cancer.RecruitingNCT06778382Phase 2
- Continuation of First-line Therapy With Radiotherapy Versus Early Switch to Second-line Therapy in Oligoprogressive HCCRecruitingNCT06841172Phase 3
- Spatially Fractionated Radiotherapy Versus Conventional Radiotherapy in the Treatment of Soft Tissue SarcomaRecruitingNCT06980259Not applicable
- SFRT and SCART in Radiotherapy for Bone Metastases With Soft TissueRecruitingNCT06987370Not applicable
- Iparomlimab/Tuvonralimab Integrating With Total Neoadjuvant Therapy for pMMR/MSS Locally Advanced Rectal Cancer (IT-TNT)RecruitingNCT07026422Phase 2
- Nano-Megestrol Acetate for Cancer Cachexia in Advanced Pancreatic CancerRecruitingNCT07408505Not applicable
- Stereotactic Body Radiotherapy and NALIRIFOX for Locally Advanced Pancreatic CancerRecruitingNCT07173387Phase 2
- SBRT Followed by Ipilimumab N01, Sintilimab, Nab-Paclitaxel and Gemcitabine for Locally Advanced Pancreatic CancerRecruitingNCT07683221Phase 2
- A Multicenter, Randomized, Controlled Phase III Clinical Trial on Adjuvant Intensified Therapy for Patients With Residual Disease After Neoadjuvant Treatment for Triple-negative Breast CancerNot yet recruitingNCT07869628Phase 3
- IMPT Versus IMRT for Diffuse Intrinsic Pontine GliomaNot yet recruitingNCT07869524Phase 3
- Clinical Evaluation of 177Lu-FAP-VG11 Injection in Patients With Fibroblast Activation Protein -Positive Advanced Solid TumoursRecruitingNCT07808177Early Phase 1
- Short-Course Radiotherapy Followed by CAPOX With or Without Iparomlimab and Tuvonralimab in pMMR/MSS Locally Advanced Rectal CancerRecruitingNCT07686640Phase 3
- Efficacy of Stereotactic Body Radiotherapy (SBRT) Combined With Maintenance Therapy Compared to Maintenance Therapy Alone in Advanced Pancreatic CancerRecruitingNCT07600268Phase 2
- Fruquintinib Combined With Sintilimab ± Radiotherapy for Third-line Treatment of Colorectal Cancer With Liver MetastasesRecruitingNCT06356584Phase 2
- Adapted Guided Stereotactic Body Radiotherapy Combined With Chemotherapy and Enhancement of Novel Drug Ivonescimab for Pancreatic Cancer (ASCEND)RecruitingNCT06844422Phase 1/2
- Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial CarcinomaRecruitingNCT06532539Phase 2
- Posaconazole Plus PD-1 Inhibitors and Chemotherapy vs PD-1 Inhibitors and Chemotherapy in Neoadjuvant Therapy for Triple Negative Breast CancerRecruitingNCT06802757Phase 2
- The Prognostic Impact of HER2 Expression in Non-Metastatic HER2-Positive Breast Cancer Treated With Dual HER2-Targeted TherapyRecruitingNCT07376174
- Compare Radiotherapy Plus Nimotuzumab Versus Radiotherapy Alone in Platinum-ineligible Patients With Locoregionally Advanced Head and Neck Squamous Cell CarcinomaRecruitingNCT07333274Phase 3
- Identification of HER2-Positive Breast Cancer Molecular Characterization and SubtypesNot yet recruitingNCT07187752Not applicable
- Early Screening Cohort Study of Multiple Gastrointestinal TumorsRecruitingNCT07106424
- Efficacy and Safety of Lobaplatin and Carboplatin as Neoadjuvant Therapy in HER-2 Positive Breast CancerNot yet recruitingNCT07093931Phase 4
- Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical CancerRecruitingNCT06942416Phase 2
- Phase I-II Clinical Study of Taurine for External Use in the Prevention and Treatment of Acute Radiation Skin InjuryRecruitingNCT06847555Phase 1/2
- Evaluation of the Efficacy and Safety of Pazopanib in Combination with TGI/CIV for Recurrent or Refractory Rhabdomyosarcoma in Children or AdolescentsRecruitingNCT06816771Phase 2
- Trilaciclib in Preventing Hematopoietic Suppression in Patients with Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaNot yet recruitingNCT06714266Phase 2
- A Multi-cohort Study of Efbemalenograstim Alfa Injection for Preventing ANC Reduction in Solid Tumor Patients Post Immune-chemotherapy.Not yet recruitingNCT06649448Not applicable
- A Phase II Clinical Study of Epigallocatechin-3-gallate in Patients With Esophageal Squamous CancerRecruitingNCT06398405Phase 2
- Neoadjuvant Camrelizumab Combined With Chemotherapy for Resectable Stage IIIA-IIIB NSCLCRecruitingNCT06241807Phase 2
- A Study of Orelabrutinib Plus R-CHOP in Treatment-naïve Patients With Double Expression Diffuse Large B-cell LymphomaRecruitingNCT05933967Phase 2
- Oxygen Atomizing Inhalation of EGCG in the Treatment Interstitial Pneumonia in Cancer PatientsRecruitingNCT05758571Phase 1/2
- Efficacy and Safety of Prophylactic Cranial Irradiation Versus MRI Surveillance in Patients With Limited-stage Small Cell Lung Cancer Who Achieved Remission After First-line ChemoradiotherapyRecruitingNCT04829708Phase 3
- Oral Green Tea Extract for Small Cell Lung CancerAvailableNCT01317953
- Capecitabine in HER-2 Positive Breast Cancer With Pathologic Residual Tumors After Preoperative ChemotherapyNot yet recruitingNCT03684863Phase 2
- SBRT Plus Systemic Therapy vs Systemic Therapy Alone in BCLC C Hepatocellular CarcinomaSuspendedNCT07274774Phase 2
- Adaptive Boost Radiotherapy to Primary Lesions and Positive Nodes in the Neoadjuvant Treatment of Locally Advanced Rectal CancerActive, not recruitingNCT06246344Phase 3
- Olanzapine Dose Comparison for the Prevention of HER-INV: A Network Meta-AnalysisCompletedNCT07403370
- A Phase II Clinical Trial of Ivonescimab Plus Third-generation EGFR-TKIs in Advanced Non-small Cell Lung Cancer With Gradual or Potential Progression After EGFR-TKIs TreatmentActive, not recruitingNCT07669051Phase 2
- A Trial of Conversion Treatment of HAIC Combined With Camrelizumab and Apatinib for Unresected Hepatocellular CarcinomaCompletedNCT05099848Phase 2
- Stereotactic Centralized Ablative Radiotherapy for Locally Advanced Pancreatic Cancer: A Single-Arm Phase I Safety and Feasibility StudySuspendedNCT07173374Phase 1
- Radiotherapy Delays Second-line Drug Therapy for Oligo Progressive Primary Liver CancerCompletedNCT06261047
- CXCR4 PET/CT for Predicting Outcome in Limited-Stage Small Cell Lung CancerCompletedNCT07316309
- WASPE Sleep Adjustment for Children Aged 0-4 Years Undergoing Radiation TherapyCompletedNCT06443632Not applicable
- Study of of Oxygen Nebulized Inhalation EGCG in Cancer Patients With New Coronary PneumoniaCompletedNCT06924749Phase 2
- First-line Treatment for Unresectable Locally Advanced Distal Cholangiocarcinoma Combining Radiotherapy and HAICTerminatedNCT06370663Phase 2
- SHR-1316 Combined With Chemotherapy and Chest Radiotherapy in ES-SCLCActive, not recruitingNCT04562337Phase 2